Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women

Jessica A. Kahn, Susan L. Rosenthal, Yan Jin, Bin Huang, Azadeh Namakydoust, Gregory Zimet

Research output: Contribution to journalArticle

162 Citations (Scopus)

Abstract

OBJECTIVE: To estimate rates of human papillomavirus (HPV) vaccination, factors associated with intention and belief in one's ability (self-efficacy) to receive the vaccine, and prevalence of vaccine-type HPV during the first year after an HPV-6, HPV-11, HPV-16, HPV-18 vaccine was licensed. METHODS: Sexually experienced females 13-26 years of age (N=409) were recruited from three primary care clinics, completed a questionnaire, and underwent cervicovaginal HPV DNA testing. Outcome measures were HPV vaccination, intention and belief in one's ability to receive the HPV vaccine in the next year, and prevalence of vaccine-type HPV. Factors independently associated with intention and belief in one's ability to receive the HPV vaccine were determined by logistic regression. RESULTS: Five percent of participants had received at least one HPV vaccine dose, 66% intended to receive the vaccine, 65% were confident they could find the time to get vaccinated, 54% believed that they could receive all three shots, and 42% believed that they could afford vaccination. Sixty-eight percent of women were HPV-positive: 9% for HPV-6, 3% for HPV-11, 17% for HPV-16, and 12% for HPV-18. Factors independently associated with intention included believing that influential people would approve of vaccination, higher perceived severity of cervical cancer or genital warts, fewer safety barriers, and pregnancy history. Factors associated with a high belief in one's ability to receive the vaccine included perceived severity of HPV, sexually transmitted disease history, insurance coverage, and fewer practical barriers to vaccination. CONCLUSION: Interventions that aim to increase intention and belief in one's ability to receive HPV vaccines, which may lead to higher vaccination rates, should address personal beliefs about vaccination as well as systemic barriers to vaccination.

Original languageEnglish (US)
Pages (from-to)1103-1110
Number of pages8
JournalObstetrics and Gynecology
Volume111
Issue number5
DOIs
StatePublished - May 2008
Externally publishedYes

Fingerprint

Papillomavirus Vaccines
Vaccination
Aptitude
Human papillomavirus 11
Human papillomavirus 6
Human papillomavirus 18
Vaccines
Human papillomavirus 16
Condylomata Acuminata
Reproductive History
Insurance Coverage
Self Efficacy
Sexually Transmitted Diseases
Uterine Cervical Neoplasms
Primary Health Care
Logistic Models
Outcome Assessment (Health Care)
Safety
DNA

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. / Kahn, Jessica A.; Rosenthal, Susan L.; Jin, Yan; Huang, Bin; Namakydoust, Azadeh; Zimet, Gregory.

In: Obstetrics and Gynecology, Vol. 111, No. 5, 05.2008, p. 1103-1110.

Research output: Contribution to journalArticle

Kahn, Jessica A. ; Rosenthal, Susan L. ; Jin, Yan ; Huang, Bin ; Namakydoust, Azadeh ; Zimet, Gregory. / Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. In: Obstetrics and Gynecology. 2008 ; Vol. 111, No. 5. pp. 1103-1110.
@article{308acefb1e73489f891001b9369dabec,
title = "Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women",
abstract = "OBJECTIVE: To estimate rates of human papillomavirus (HPV) vaccination, factors associated with intention and belief in one's ability (self-efficacy) to receive the vaccine, and prevalence of vaccine-type HPV during the first year after an HPV-6, HPV-11, HPV-16, HPV-18 vaccine was licensed. METHODS: Sexually experienced females 13-26 years of age (N=409) were recruited from three primary care clinics, completed a questionnaire, and underwent cervicovaginal HPV DNA testing. Outcome measures were HPV vaccination, intention and belief in one's ability to receive the HPV vaccine in the next year, and prevalence of vaccine-type HPV. Factors independently associated with intention and belief in one's ability to receive the HPV vaccine were determined by logistic regression. RESULTS: Five percent of participants had received at least one HPV vaccine dose, 66{\%} intended to receive the vaccine, 65{\%} were confident they could find the time to get vaccinated, 54{\%} believed that they could receive all three shots, and 42{\%} believed that they could afford vaccination. Sixty-eight percent of women were HPV-positive: 9{\%} for HPV-6, 3{\%} for HPV-11, 17{\%} for HPV-16, and 12{\%} for HPV-18. Factors independently associated with intention included believing that influential people would approve of vaccination, higher perceived severity of cervical cancer or genital warts, fewer safety barriers, and pregnancy history. Factors associated with a high belief in one's ability to receive the vaccine included perceived severity of HPV, sexually transmitted disease history, insurance coverage, and fewer practical barriers to vaccination. CONCLUSION: Interventions that aim to increase intention and belief in one's ability to receive HPV vaccines, which may lead to higher vaccination rates, should address personal beliefs about vaccination as well as systemic barriers to vaccination.",
author = "Kahn, {Jessica A.} and Rosenthal, {Susan L.} and Yan Jin and Bin Huang and Azadeh Namakydoust and Gregory Zimet",
year = "2008",
month = "5",
doi = "10.1097/AOG.0b013e31817051fa",
language = "English (US)",
volume = "111",
pages = "1103--1110",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women

AU - Kahn, Jessica A.

AU - Rosenthal, Susan L.

AU - Jin, Yan

AU - Huang, Bin

AU - Namakydoust, Azadeh

AU - Zimet, Gregory

PY - 2008/5

Y1 - 2008/5

N2 - OBJECTIVE: To estimate rates of human papillomavirus (HPV) vaccination, factors associated with intention and belief in one's ability (self-efficacy) to receive the vaccine, and prevalence of vaccine-type HPV during the first year after an HPV-6, HPV-11, HPV-16, HPV-18 vaccine was licensed. METHODS: Sexually experienced females 13-26 years of age (N=409) were recruited from three primary care clinics, completed a questionnaire, and underwent cervicovaginal HPV DNA testing. Outcome measures were HPV vaccination, intention and belief in one's ability to receive the HPV vaccine in the next year, and prevalence of vaccine-type HPV. Factors independently associated with intention and belief in one's ability to receive the HPV vaccine were determined by logistic regression. RESULTS: Five percent of participants had received at least one HPV vaccine dose, 66% intended to receive the vaccine, 65% were confident they could find the time to get vaccinated, 54% believed that they could receive all three shots, and 42% believed that they could afford vaccination. Sixty-eight percent of women were HPV-positive: 9% for HPV-6, 3% for HPV-11, 17% for HPV-16, and 12% for HPV-18. Factors independently associated with intention included believing that influential people would approve of vaccination, higher perceived severity of cervical cancer or genital warts, fewer safety barriers, and pregnancy history. Factors associated with a high belief in one's ability to receive the vaccine included perceived severity of HPV, sexually transmitted disease history, insurance coverage, and fewer practical barriers to vaccination. CONCLUSION: Interventions that aim to increase intention and belief in one's ability to receive HPV vaccines, which may lead to higher vaccination rates, should address personal beliefs about vaccination as well as systemic barriers to vaccination.

AB - OBJECTIVE: To estimate rates of human papillomavirus (HPV) vaccination, factors associated with intention and belief in one's ability (self-efficacy) to receive the vaccine, and prevalence of vaccine-type HPV during the first year after an HPV-6, HPV-11, HPV-16, HPV-18 vaccine was licensed. METHODS: Sexually experienced females 13-26 years of age (N=409) were recruited from three primary care clinics, completed a questionnaire, and underwent cervicovaginal HPV DNA testing. Outcome measures were HPV vaccination, intention and belief in one's ability to receive the HPV vaccine in the next year, and prevalence of vaccine-type HPV. Factors independently associated with intention and belief in one's ability to receive the HPV vaccine were determined by logistic regression. RESULTS: Five percent of participants had received at least one HPV vaccine dose, 66% intended to receive the vaccine, 65% were confident they could find the time to get vaccinated, 54% believed that they could receive all three shots, and 42% believed that they could afford vaccination. Sixty-eight percent of women were HPV-positive: 9% for HPV-6, 3% for HPV-11, 17% for HPV-16, and 12% for HPV-18. Factors independently associated with intention included believing that influential people would approve of vaccination, higher perceived severity of cervical cancer or genital warts, fewer safety barriers, and pregnancy history. Factors associated with a high belief in one's ability to receive the vaccine included perceived severity of HPV, sexually transmitted disease history, insurance coverage, and fewer practical barriers to vaccination. CONCLUSION: Interventions that aim to increase intention and belief in one's ability to receive HPV vaccines, which may lead to higher vaccination rates, should address personal beliefs about vaccination as well as systemic barriers to vaccination.

UR - http://www.scopus.com/inward/record.url?scp=42949171490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42949171490&partnerID=8YFLogxK

U2 - 10.1097/AOG.0b013e31817051fa

DO - 10.1097/AOG.0b013e31817051fa

M3 - Article

C2 - 18448742

AN - SCOPUS:42949171490

VL - 111

SP - 1103

EP - 1110

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 5

ER -